529 related articles for article (PubMed ID: 25231249)
1. Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
Eun JW; Bae HJ; Shen Q; Park SJ; Kim HS; Shin WC; Yang HD; Jin CY; You JS; Kang HJ; Kim H; Ahn YM; Park WS; Lee JY; Nam SW
J Appl Toxicol; 2015 Feb; 35(2):152-64. PubMed ID: 25231249
[TBL] [Abstract][Full Text] [Related]
2. Is toxicogenomics a more reliable and sensitive biomarker than conventional indicators from rats to predict drug-induced liver injury in humans?
Zhang M; Chen M; Tong W
Chem Res Toxicol; 2012 Jan; 25(1):122-9. PubMed ID: 22122743
[TBL] [Abstract][Full Text] [Related]
3. Comparative gene and protein expression analyses of a panel of cytokines in acute and chronic drug-induced liver injury in rats.
Hanafusa H; Morikawa Y; Uehara T; Kaneto M; Ono A; Yamada H; Ohno Y; Urushidani T
Toxicology; 2014 Oct; 324():43-54. PubMed ID: 25051504
[TBL] [Abstract][Full Text] [Related]
4. Characteristic molecular signature for early detection and prediction of persistent organic pollutants in rat liver.
Jung KH; Kim JK; Kim MG; Noh JH; Eun JW; Bae HJ; Chang YG; Shen Q; Park WS; Lee JY; Nam SW
Environ Sci Technol; 2012 Dec; 46(23):12882-9. PubMed ID: 23153324
[TBL] [Abstract][Full Text] [Related]
5. The liver toxicity biomarker study: phase I design and preliminary results.
McBurney RN; Hines WM; Von Tungeln LS; Schnackenberg LK; Beger RD; Moland CL; Han T; Fuscoe JC; Chang CW; Chen JJ; Su Z; Fan XH; Tong W; Booth SA; Balasubramanian R; Courchesne PL; Campbell JM; Graber A; Guo Y; Juhasz PJ; Li TY; Lynch MD; Morel NM; Plasterer TN; Takach EJ; Zeng C; Beland FA
Toxicol Pathol; 2009 Jan; 37(1):52-64. PubMed ID: 19171931
[TBL] [Abstract][Full Text] [Related]
6. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress/reactive metabolite gene expression signature in rat liver detects idiosyncratic hepatotoxicants.
Leone A; Nie A; Brandon Parker J; Sawant S; Piechta LA; Kelley MF; Mark Kao L; Jim Proctor S; Verheyen G; Johnson MD; Lord PG; McMillian MK
Toxicol Appl Pharmacol; 2014 Mar; 275(3):189-97. PubMed ID: 24486436
[TBL] [Abstract][Full Text] [Related]
8. In silico models for drug-induced liver injury--current status.
Przybylak KR; Cronin MT
Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):201-17. PubMed ID: 22248266
[TBL] [Abstract][Full Text] [Related]
9. How to Diagnose and Exclude Drug-Induced Liver Injury.
Watkins PB
Dig Dis; 2015; 33(4):472-6. PubMed ID: 26159261
[TBL] [Abstract][Full Text] [Related]
10. An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury.
Oda S; Uchida Y; Aleo MD; Koza-Taylor PH; Matsui Y; Hizue M; Marroquin LD; Whritenour J; Uchida E; Yokoi T
Arch Toxicol; 2021 Jan; 95(1):149-168. PubMed ID: 32816093
[TBL] [Abstract][Full Text] [Related]
11. Are zebrafish larvae suitable for assessing the hepatotoxicity potential of drug candidates?
Mesens N; Crawford AD; Menke A; Hung PD; Van Goethem F; Nuyts R; Hansen E; Wolterbeek A; Van Gompel J; De Witte P; Esguerra CV
J Appl Toxicol; 2015 Sep; 35(9):1017-29. PubMed ID: 25663337
[TBL] [Abstract][Full Text] [Related]
12. Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats.
Yamazaki M; Miyake M; Sato H; Masutomi N; Tsutsui N; Adam KP; Alexander DC; Lawton KA; Milburn MV; Ryals JA; Wulff JE; Guo L
Toxicol Appl Pharmacol; 2013 Apr; 268(1):79-89. PubMed ID: 23360887
[TBL] [Abstract][Full Text] [Related]
13. Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma.
Mattes W; Davis K; Fabian E; Greenhaw J; Herold M; Looser R; Mellert W; Groeters S; Marxfeld H; Moeller N; Montoya-Parra G; Prokoudine A; van Ravenzwaay B; Strauss V; Walk T; Kamp H
Toxicol Lett; 2014 Nov; 230(3):467-78. PubMed ID: 25086301
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.
Goda K; Takahashi T; Kobayashi A; Shoda T; Kuno H; Sugai S
J Toxicol Sci; 2016; 41(5):605-15. PubMed ID: 27665770
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFα-mediated hepatotoxicity.
Fredriksson L; Wink S; Herpers B; Benedetti G; Hadi M; de Bont H; Groothuis G; Luijten M; Danen E; de Graauw M; Meerman J; van de Water B
Toxicol Sci; 2014 Jul; 140(1):144-59. PubMed ID: 24752500
[TBL] [Abstract][Full Text] [Related]
16. Current challenges and controversies in drug-induced liver injury.
Corsini A; Ganey P; Ju C; Kaplowitz N; Pessayre D; Roth R; Watkins PB; Albassam M; Liu B; Stancic S; Suter L; Bortolini M
Drug Saf; 2012 Dec; 35(12):1099-117. PubMed ID: 23137150
[TBL] [Abstract][Full Text] [Related]
17. Unique gene expression and hepatocellular injury in the lipopolysaccharide-ranitidine drug idiosyncrasy rat model: comparison with famotidine.
Luyendyk JP; Lehman-McKeeman LD; Nelson DM; Bhaskaran VM; Reilly TP; Car BD; Cantor GH; Maddox JF; Ganey PE; Roth RA
Toxicol Sci; 2006 Apr; 90(2):569-85. PubMed ID: 16415329
[TBL] [Abstract][Full Text] [Related]
18. Coagulation-dependent gene expression and liver injury in rats given lipopolysaccharide with ranitidine but not with famotidine.
Luyendyk JP; Lehman-McKeeman LD; Nelson DM; Bhaskaran VM; Reilly TP; Car BD; Cantor GH; Deng X; Maddox JF; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2006 May; 317(2):635-43. PubMed ID: 16401727
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and pathological features in 138 cases of drug-induced liver injury].
Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
[TBL] [Abstract][Full Text] [Related]
20. A novel cell-based assay for the evaluation of immune- and inflammatory-related gene expression as biomarkers for the risk assessment of drug-induced liver injury.
Oda S; Matsuo K; Nakajima A; Yokoi T
Toxicol Lett; 2016 Jan; 241():60-70. PubMed ID: 26546780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
